#EuroPCR 2024 Major LBTs: NOTION-2 This study provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with #TAVI compared to SAVR. In this population, TAVI and SAVR showed similar rates of the primary endpoint at 1 year,

#EuroPCR 2024 Major LBT – LANDMARK Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after #TAVI with inferior safety & efficacy for some of them. Validation of MyVal non-inferiority to the most widely used

#EuroPCR 2024 Major LBTs: REC-CAGEFREE II The results of this pioneering study, presented by Ling Tao. provides the 1st randomised data concerning the use of antiplatelet therapy in ACS patients treated with DCB. #interventionalcardiology

Everything we have learned so far about the revascularization of non-culprit lesions in patients with acute myocardial infarction and multivessel disease... in 1 minute.

This is a study inspired from and dedicated to Sanjay Kaul, where we investigated the effect of using absolute rather than relative noninferiority margins in cardiovascular randomized trials. Recalculating noninferiority margins based on actual event rates, rather than expected

How to retrieve your Prostyle when it gets stuck In challenging anatomies, the Prostyle may get stuck due to calcification, leading to urgent vascular surgery and increasing the operative risk for the patients. This #MyToolKit 🧰⚙️🪛 tutorial shows a step-by-step bailout

New 2024 #ESCGuidelines on #Afib 🆕! Use the CHA2DS2-VA score (without Sc) #ESCCongress European Society of Cardiology

How many times have we seen this flow chart on the duration of DAPT change over the years? Let’s summarize the situation regarding class I recommendations (“must be done”) as reported in the new 2024 guidelines on chronic coronary syndromes: - High bleeding risk patient: DAPT

The OCEANIC-AF trial, comparing asundexian to apixaban in patients with atrial fibrillation was halted early due to a significantly higher incidence of stroke or systemic embolism in the asundexian group. The findings raise questions about the adequacy of factor XIa inhibition

Live from the #ESCCongress 2024 in London 🇬🇧 NOTION 3 📊: PCI with #TAVI reduced death, MI, or urgent revascularization compared to TAVI alone but increased minor bleeding. However, the decision to proceed with PCI should be individualized according to patient characteristics.

This comprehensive review embraces the latest evidences of coronary revascularization management in transcatheter aortic valve implantation candidates; now available online on #ExpertReviewofMedicalDevices tandfonline.com/doi/full/10.10… #CAD #TAVI #CoronaryArteryDisease #CardioTwitter

[IT] Asundexian per la Fibrillazione Atriale: presentati all’ESC2024 i risultati dello studio OCEANIC-AF interrotto precocemente per endpoint ischemici elevati in confronto ad Apixaban. È ancora troppo presto per l’era degli antagonisti del fattore XIa? centrolottainfarto.com/allnews/antago…

How to deal with ilio-femoral tortuosity during #TAVI : the buddy wire technique to straighten the pathway. 🔗 pcronline.com/Cases-resource… In this new My Toolkit 🧰⚙️🔨 article, Vincenzo Cesario Chiara De Biase and Didier Tchetche share a practical step-by-step method to overcome aortic and

Randomized trials of cangrelor did not focus on STEMI, nor did they directly compare cangrelor to ticagrelor (the current standard of care). What is the relative efficacy and safety of downstream cangrelor compared with ticagrelor pretreatment?tinyurl.com/mtmkaad7

The ENNA project. A collaborative effort of cardiologists, pharmacists and general practitioners is the central core of the dyslipidemia management pathway proposed in the province of Enna. ajconline.org/article/S0002-… #ENNAproject #dyslipidemia #cardiology #collaboration #patientcare

📌📊I’m proud to be part of the Scientific Committee for #CCC2025 once again this year. It’s truly an honor to moderate two sessions alongside amazing colleagues and friends. 📅🖌️We look forward to welcoming you to 42nd edition of Conoscere e Curare il Cuore, 20-23 March 2025

Clinical feasibility of a quick response code-based digital self-reporting of medication adherence: results in patients on ticagrelor therapy from the APOLLO-QR observational study 👉 ow.ly/KTf750W42ul #EHJDigital Nico Bruining EiC EHJ Digital Health rafavidalperez Folkert Asselbergs Ruben Casado Arroyo

#mdpijcm #Editor’s Choice Paper🔍 👏 Citations 11 Novel and Emerging LDL-C Lowering Strategies: A New Era of #Dyslipidemia Management 🎯mdpi.com/2687694 by Federica Agnello et al. Marco Barbanti Lorenzo Scalia Federica Agnello Università Kore di Enna MDPI Medicine & Pharmacology